Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trial
Niklas Dyrby Johansen(Gentofte Hospital), Tor Biering‐Sørensen(Copenhagen University Hospital), Brian Claggett(National Heart Lung and Blood Institute), Palle Valentiner‐Branth(Statens Serum Institut), Matthew M. Loiacono(Sanofi (United States)), Anne Marie Reimer Jensen(University of Copenhagen), Kristoffer Grundtvig Skaarup(University of Copenhagen), Lars Køber(University of Copenhagen), Gunnar Gislason(Copenhagen University Hospital), Jens‐Ulrik Stæhr Jensen(University of Copenhagen), Sandrine Samson(Sanofi (France)), Marine Dufournet(Sanofi (France)), Scott D. Solomon(Brigham and Women's Hospital), Carsten Schade Larsen(Emory Healthcare), Daniel Modin(University of Copenhagen), Tyra Grove Krause(Statens Serum Institut), Rebecca C. Harris(Nottingham University Hospitals NHS Trust), Martin Landray(Gentofte Hospital), Pradeesh Sivapalan(Gentofte Hospital), Nino Emanuel Landler(University of Copenhagen), Lasse S. Vestergaard, Joshua Nealon(Sanofi (France))
Cited by 23
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k